Further research shows that the test is accurate.
When it comes to genetic neurological and neuromuscular diseases, screening early is key to getting the right treatment. A new DNA test developed by researchers at the Garvan Institute of Medical Research in Sydney may help in this process, as reported by the institution in a press release published on Saturday.
Garvan researchers have shown how new genomic sequencing technology can reduce the ‘diagnostic odyssey’ experienced by people with rare neurological and neuromuscular diseases.
Comments are closed.